Other institutional investors
Biotech Investor · 4 portfolio companies
Portfolio
4
Combined Value
$6.0B
Focus Areas
5
Top Stage
Phase 1
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Vera Therapeutics | $2.9B |
| Tango Therapeutics | $2.8B |
| Adagene | $171.1M |
| Nkarta | $152.0M |